ProfileGDS4718 / 204620_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 77% 84% 64% 69% 71% 84% 68% 78% 68% 65% 70% 77% 82% 75% 79% 67% 89% 72% 93% 76% 76% 69% 73% 73% 88% 76% 88% 66% 58% 63% 91% 78% 64% 93% 89% 55% 85% 67% 93% 67% 72% 98% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5080665
GSM549102patient 115, normal, homogenized [OPG study]7.4725977
GSM549104patient 119, normal, homogenized [OPG study]8.4643484
GSM549108patient 138, normal, homogenized [OPG study]6.4397364
GSM549119patient 077, normal, homogenized [OPG study]6.7837669
GSM549133patient 032, cancer, homogenized [OPG study]6.9771271
GSM549139patient 042, cancer, homogenized [OPG study]8.415284
GSM549099patient 107, normal, homogenized [OPG study]6.704868
GSM549109patient 139, normal, homogenized [OPG study]7.5393678
GSM549110patient 046, normal, homogenized [OPG study]6.692268
GSM549114patient 063, normal, homogenized [OPG study]6.4550365
GSM549122patient 082, normal, homogenized [OPG study]6.9090270
GSM549134patient 033, cancer, homogenized [OPG study]7.5985177
GSM549136patient 036, cancer, homogenized [OPG study]8.1830782
GSM549140patient 044, cancer, homogenized [OPG study]7.424275
GSM549111patient 047, normal, homogenized [OPG study]7.8190279
GSM549113patient 057, normal, homogenized [OPG study]6.5931367
GSM549132patient 031, cancer, homogenized [OPG study]8.9498789
GSM549137patient 038, cancer, homogenized [OPG study]7.0814472
GSM549142patient 047, cancer, homogenized [OPG study]9.3127393
GSM549100patient 110, normal, homogenized [OPG study]7.3756176
GSM549107patient 135, normal, homogenized [OPG study]7.4591376
GSM549115patient 068, normal, homogenized [OPG study]6.8544369
GSM549116patient 072, normal, homogenized [OPG study]7.2007373
GSM549120patient 078, normal, homogenized [OPG study]7.0956373
GSM549131patient 030, cancer, homogenized [OPG study]8.9437688
GSM549118patient 074, normal, homogenized [OPG study]7.449576
GSM549129patient 027, cancer, homogenized [OPG study]8.8514388
GSM549123patient 088, normal, homogenized [OPG study]6.536466
GSM549124patient 006, cancer, homogenized [OPG study]5.9971558
GSM549126patient 015, cancer, homogenized [OPG study]6.3357663
GSM549128patient 025, cancer, homogenized [OPG study]9.2955691
GSM549103patient 117, normal, homogenized [OPG study]7.5507378
GSM549117patient 073, normal, homogenized [OPG study]6.3199364
GSM549138patient 041, cancer, homogenized [OPG study]9.8340293
GSM549141patient 045, cancer, homogenized [OPG study]9.1486389
GSM549130patient 028, cancer, homogenized [OPG study]5.7737255
GSM549101patient 111, normal, homogenized [OPG study]8.465685
GSM549105patient 128, normal, homogenized [OPG study]6.6665767
GSM549106patient 134, normal, homogenized [OPG study]9.8533993
GSM549112patient 048, normal, homogenized [OPG study]6.6007767
GSM549125patient 011, cancer, homogenized [OPG study]7.0438672
GSM549127patient 024, cancer, homogenized [OPG study]10.985298
GSM549135patient 035, cancer, homogenized [OPG study]8.6463386